Vu Peter D, Pinkhasova Dorina, Sarwary Zohal B, Rita Markaryan Anush, Mousa Bakir, Viswanath Omar, Robinson Christopher L, Varrassi Giustino, Orhurhu Vwaire, Urits Ivan, Hasoon Jamal
Physical Medicine and Rehabilitation McGovern Medical School at The University of Texas Health Science Center at Houston.
Creighton University School of Medicine.
Orthop Rev (Pavia). 2024 Sep 21;16:123443. doi: 10.52965/001c.123443. eCollection 2024.
Spinal cord stimulation (SCS) is a minimally invasive and reversible therapy for the treatment of severe neuropathic pain. There are several biologic complications that can arise during the implantation of SCS systems. This review aims to consolidate recent research on complications associated with SCS, specifically focusing on biologic complications.
Biologic complications are less frequently encountered compared to device-related complications but may have more severe consequences. Biologic complications covered in this review include infection, seromas, hematomas, dural puncture, nerve/spinal cord injury, and therapy habituation.
The application of SCS remains a viable and effective choice for managing neuropathic pain conditions. It is crucial for physicians to carefully consider potential complications before proceeding with SCS trials and implantation. Familiarity with biologic complications is critical for patient safety and to optimize patient outcomes.
脊髓刺激（SCS）是一种用于治疗严重神经性疼痛的微创且可逆的疗法。在SCS系统植入过程中可能会出现多种生物学并发症。本综述旨在汇总近期关于SCS相关并发症的研究，特别关注生物学并发症。
与设备相关并发症相比，生物学并发症的发生率较低，但可能具有更严重的后果。本综述涵盖的生物学并发症包括感染、血清肿、血肿、硬膜穿刺、神经/脊髓损伤和治疗适应性。
SCS的应用仍然是治疗神经性疼痛的可行且有效的选择。医生在进行SCS试验和植入之前仔细考虑潜在并发症至关重要。熟悉生物学并发症对于患者安全和优化患者预后至关重要。
